Parkinson's patient can swim again after stem cell transplant
Newsweek - 14-May-2020Study and procedure represent a milestone in personalized medicine for Parkinson's
Join the club for FREE to access the whole archive and other member benefits.
South Korean neuroscientist, McLean Hospital
Dr. Kim’s lab also investigates translational stem cell research and personalized cell therapy of PD and is optimizing reprogramming and differentiation methods. His lab has pioneered the generation of clinical grade induced pluripotent stem (iPS) cells using non-viral reprogramming methods such as direct delivery of reprogrammed proteins and novel episomal methods, and has recently identified novel mechanisms underlying metabolic reprogramming during human induced pluripotency.
Visit website: https://www.mcleanhospital.org/profile/kwang-soo-kim
See also: McLean Hospital - Psychiatric hospital, affiliate of Harvard Medical School
Details last updated 15-May-2020
Study and procedure represent a milestone in personalized medicine for Parkinson's
New therapeutic personalized strategy could bring back movement to those suffering